These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 16517058)
1. Modifying effect of dietary sesaminol glucosides on the formation of azoxymethane-induced premalignant lesions of rat colon. Sheng H; Hirose Y; Hata K; Zheng Q; Kuno T; Asano N; Yamada Y; Hara A; Osawa T; Mori H Cancer Lett; 2007 Feb; 246(1-2):63-8. PubMed ID: 16517058 [TBL] [Abstract][Full Text] [Related]
2. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
3. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats. Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582 [TBL] [Abstract][Full Text] [Related]
4. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913 [TBL] [Abstract][Full Text] [Related]
6. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats. Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Mori H; Yoshimi N Cancer Lett; 2004 Mar; 205(2):133-41. PubMed ID: 15036645 [TBL] [Abstract][Full Text] [Related]
7. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031 [TBL] [Abstract][Full Text] [Related]
8. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats. Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane. Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338 [TBL] [Abstract][Full Text] [Related]
10. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats. Williams D; Verghese M; Walker LT; Boateng J; Shackelford L; Chawan CB Food Chem Toxicol; 2007 Jan; 45(1):153-9. PubMed ID: 17045379 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon. Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022 [TBL] [Abstract][Full Text] [Related]
12. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Femia AP; Dolara P; Caderni G Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057 [TBL] [Abstract][Full Text] [Related]
15. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Raju J; Patlolla JM; Swamy MV; Rao CV Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834 [TBL] [Abstract][Full Text] [Related]
17. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats. Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531 [TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane. Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282 [TBL] [Abstract][Full Text] [Related]
19. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors. Dai W; Liu T; Wang Q; Rao CV; Reddy BS Int J Oncol; 2002 Jan; 20(1):121-6. PubMed ID: 11743651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]